aTyr Pharma Inc. (LIFE) Financial Statements (2024 and earlier)

Company Profile

Business Address 10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments98,16666,146107,91131,68931,14449,545
Cash and cash equivalents22,5449,9812,33616,9529,21022,962
Short-term investments75,62256,165105,57514,73721,93426,583
Receivables2,43611,7754352,039  
Prepaid expense2,3902,9505,2231,803  
Other undisclosed current assets     7811,258
Total current assets:102,99280,871113,56935,53131,92550,803
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization1,7881,248   
Operating lease, right-of-use asset6,7277,2501,2672,0832,821
Property, plant and equipment5,5313,0595438991,2701,853
Restricted cash and investments3,4843,165    
Other noncurrent assets13119315821317290
Total noncurrent assets:17,66114,9151,9683,1954,2631,943
TOTAL ASSETS:120,65395,786115,53738,72636,18852,746
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,08812,9685,0335,0033,2233,066
Accounts payable3,5293,1061,0311,4318471,040
Accrued liabilities11,5599,8624,0023,5722,3762,026
Deferred revenue     208
Debt497264  9,4927,767
Other undisclosed current liabilities831630980861  
Total current liabilities:16,41613,8626,0135,86412,92310,833
Noncurrent Liabilities
Long-term debt and lease obligation1,4281,0073981,3782,2398,263
Long-term debt, excluding current maturities      8,263
Finance lease, liability1,4281,007   
Liabilities, other than long-term debt12,3399,633    
Operating lease, liability12,3399,6333981,3782,239
Other undisclosed noncurrent liabilities   (398)(1,378)  
Total noncurrent liabilities:13,76710,6403981,3782,2398,263
Total liabilities:30,18324,5026,4117,24215,16219,096
Equity
Equity, attributable to parent90,65871,464109,30131,65021,18633,650
Preferred stock     22
Common stock63292811431
Additional paid in capital558,692489,502481,832370,210343,524332,378
Accumulated other comprehensive loss(74)(433)(263)(43)(40)(60)
Accumulated deficit(468,023)(417,634)(372,296)(338,528)(322,304)(298,701)
Equity, attributable to noncontrolling interest(188)(180)(175)(166)(160) 
Total equity:90,47071,284109,12631,48421,02633,650
TOTAL LIABILITIES AND EQUITY:120,65395,786115,53738,72636,18852,746

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues35310,386 10,455422 
Gross profit:35310,386 10,455422 
Operating expenses(55,272)(56,790)(34,015)(26,366)(23,400)(32,820)
Operating loss:(54,919)(46,404)(34,015)(15,911)(22,978)(32,820)
Nonoperating income (expense)4,5221,061238(319)(785)(1,695)
Other nonoperating expense      (1,695)
Loss from continuing operations before equity method investments, income taxes:(50,397)(45,343)(33,777)(16,230)(23,763)(34,515)
Other undisclosed income from continuing operations before income taxes233   
Loss from continuing operations:(50,395)(45,340)(33,774)(16,230)(23,763)(34,515)
Loss before gain (loss) on sale of properties:(33,774)(16,230)(23,763)(34,515)
Other undisclosed net loss(2)(3)(3)   
Net loss:(50,397)(45,343)(33,777)(16,230)(23,763)(34,515)
Net income attributable to noncontrolling interest8596160 
Net loss available to common stockholders, diluted:(50,389)(45,338)(33,768)(16,224)(23,603)(34,515)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(50,397)(45,343)(33,777)(16,230)(23,763)(34,515)
Other undisclosed comprehensive income (loss)359(170)(220)(3)20 
Comprehensive loss:(50,038)(45,513)(33,997)(16,233)(23,743)(34,515)
Comprehensive income, net of tax, attributable to noncontrolling interest8596160 
Other undisclosed comprehensive income, net of tax, attributable to parent      60
Comprehensive loss, net of tax, attributable to parent:(50,030)(45,508)(33,988)(16,227)(23,583)(34,455)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: